Koch, D. T., Pickhard, A., Gebel, L., Buchberger, A. M. S., Bas, M., Mogler, C., . . . Wirth, M. (2017). Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation. Oncotarget.

Koch, Dominik Thomas, Anja Pickhard, Lena Gebel, Anna Maria S. Buchberger, Murat Bas, Carolin Mogler, Rudolf Reiter, Guido Piontek, and Markus Wirth. "Epidermal Growth Factor Receptor Variant III in Head and Neck Squamous Cell Carcinoma Is Not Relevant for Targeted Therapy and Irradiation." Oncotarget 2017.

Koch, Dominik Thomas, et al. "Epidermal Growth Factor Receptor Variant III in Head and Neck Squamous Cell Carcinoma Is Not Relevant for Targeted Therapy and Irradiation." Oncotarget 2017.